Among this set, however, three displayed reduced levels in the presence of AZT (Figure 6C): breast and ovarian cancer susceptibility (BRCA1, see Table 1), human homolog of double minute 2 (HDM2, see Table 1), and death inducer-obliterator 1 (DATF1, see Table 1). This evidence concerns the gene DIDO1 and ovarian carcinoma.